Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of novel immune-relevant drug target genes for Alzheimer's Disease by combining ontology inference with network analysis.

CNS neuroscience & therapeutics - 1 Dec 2018

Han Zhi-Jie, Xue Wei-Wei, Tao Lin, Zhu Feng

Abstract excerpt

AIMS: Alzheimer's disease (AD) is one of the leading causes of death in elderly people. Its pathogenesis is greatly associated with the abnormality of immune system. However, only a few immune-relevant AD drug target genes have been discovered up to now, and it is speculated that there are still many potential drug target genes of AD (at least immune-relevant genes) to be discovered. Thus, this study was designed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Antipsychotic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Databases, Factual

Share to Drug Delivery Systems

Share to Gene Expression Profiling

Share to Gene Ontology

Share to Gene Regulatory Networks

Share to Signal Transduction

Source

Open in PubMed Open full text

Identifiers

PMID: 30106219
DOI: 10.1111/cns.13051
PMCID: PMC6489817

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of novel immune-relevant drug target genes for Alzheimer's Disease by combining ontology inference with network analysis.PMID 30106219Read ↗

Screening novel drug candidates for Alzheimer’s disease by an integrated network and transcriptome analysisSemantic proximity Read ↗

Integrated Bioinformatics and Ensemble Learning Reveal Diagnostic Modeling and Drug Discovery in Alzheimer’s DiseaseSemantic proximity Read ↗

Analyzing the genes related to Alzheimer's disease via a network and pathway-based approach.Semantic proximity Read ↗

Uncovering neuroinflammation-related modules and potential repurposing drugs for Alzheimer's disease through multi-omics data integrative analysisSemantic proximity Read ↗

Network-based approach to identify molecular signatures and therapeutic agents in Alzheimer’s diseaseSemantic proximity Read ↗

Bioinformatics and machine learning-based screening of key genes in Alzheimer's disease.Semantic proximity Read ↗

A network pharmacology-based study on Alzheimer disease prevention and treatment of Qiong Yu GaoSemantic proximity Read ↗

A network pharmacology approach to identify the mechanisms and molecular targets of curcumin against Alzheimer diseaseSemantic proximity Read ↗

Novel graph theoretic biological pathway network analytics methods for analyzing and discovering Alzheimer’s disease related genesSemantic proximity Read ↗

Screening and Identification of Potential Peripheral Blood Biomarkers for Alzheimer’s Disease Based on Bioinformatics AnalysisSemantic proximity Read ↗

Comprehensive Analysis Reveals A Six-Gene Signature and Associated Drugs in Alzheimer DiseaseSemantic proximity Read ↗

A Network Pharmacology Approach to Reveal the Underlying Mechanisms of Paeonia lactiflora Pall. On the Treatment of Alzheimer’s DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.